Initial Management of Pituitary Adenomas
Diagnostic Evaluation
- The American College of Endocrinology recommends pre-contrast and post-contrast-enhanced thin-sliced pituitary MRI for detailed anatomical delineation of the adenoma 2, 3
- Visual assessment, including visual acuity and visual fields, should be performed in all patients with pituitary macroadenomas to assess for compression of the optic chiasm 1, 3
- Complete endocrine evaluation should be performed to assess for hormone hypersecretion and hypopituitarism, which is common in patients with macroadenomas 4, 5
- Genetic assessment should be offered to all patients, particularly children and young people, who have a higher likelihood of underlying genetic disease 2, 3
Treatment Approach Based on Adenoma Type
- The Endocrine Society recommends dopamine agonists as first-line treatment for prolactinomas, even for macroadenomas with visual compromise 3
- For non-functioning pituitary adenomas, transsphenoidal surgery is the treatment of choice for symptomatic cases or those threatening the visual pathway 1, 6
- For growth hormone-secreting adenomas, first-line therapy is transsphenoidal surgery 3
- For TSH-secreting adenomas, first-line therapy is surgery, and pituitary radiotherapy may be considered in patients with post-operative tumor remnant and resistance to medical therapy 3, 5
Special Considerations for Children and Young People
- Pituitary adenomas in children tend to have more occult presentation, aggressive behavior, and are more likely to have a genetic basis than in adults 7
- Treatment should be managed by a multidisciplinary team with experts from both pediatric and adult practice 3
- Boys with Cushing disease tend to have more aggressive disease with elevated BMI, shorter height, and higher plasma ACTH levels than girls 8
Post-Treatment Surveillance
- Prolactin levels should be assessed at 3-6 month intervals initially for patients with prolactinomas 8
- MRI surveillance should be performed at 3 and 6 months, and 1, 2, 3, and 5 years after surgery for non-functioning pituitary adenomas 1
- Visual assessment should be performed within 3 months of first-line therapy 1
- Regular hormone level assessments specific to the tumor type should be conducted during follow-up 1